Advertisement
Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
 QUICK SEARCH:   [advanced]


     


Clinical trials Randomized controlled (CONSORT agreement)

Citations 1-10 of 248 total displayed.

Most recent content (18 Nov 2009):

ARTICLES
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
S. Salloway, R. Sperling, S. Gilman, N. C. Fox, K. Blennow, M. Raskind, M. Sabbagh, L. S. Honig, R. Doody, C. H. van Dyck, R. Mulnard, J. Barakos, K. M. Gregg, E. Liu, I. Lieberburg, D. Schenk, R. Black, Michael Grundman For the Bapineuzumab 201 Clinical Trial Investigators
Neurology first published on November 18, 2009 as doi: WNL.0b013e3181c67808. [Abstract] Rapid PDF  

Past content (since Mar 2001):

ARTICLES
Randomized, controlled trial of telcagepant for the acute treatment of migraine
K. M. Connor, R. E. Shapiro, H. -C. Diener, S. Lucas, J. Kost, X. Fan, K. Fei, C. Assaid, C. Lines, and T. W. Ho
Neurology 2009; 73: 970-977. [Abstract] [Full text] [PDF]  

VIEWS AND REVIEWS
The present efficacy of multiple sclerosis therapeutics: Is the new 66% just the old 33%?
Eric C. Klawiter, Anne H. Cross, and Robert T. Naismith
Neurology 2009; 73: 984-990. [Abstract] [Full text] [PDF]  

ARTICLES
Very Early Constraint-Induced Movement during Stroke Rehabilitation (VECTORS): A single-center RCT
A. W. Dromerick, C. E. Lang, R. L. Birkenmeier, J. M. Wagner, J. P. Miller, T. O. Videen, W. J. Powers, S. L. Wolf, and D. F. Edwards
Neurology 2009; 73: 195-201. [Abstract] [Full text] [PDF]  

ARTICLES
Donepezil delays progression to AD in MCI subjects with depressive symptoms
P. H. Lu, S. D. Edland, E. Teng, K. Tingus, R. C. Petersen, J. L. Cummings On behalf of The Alzheimer's Disease Cooperative Study Group
Neurology 2009; 72: 2115-2121. [Abstract] [Full text] [PDF]  

EDITORIALS
Seeing injectable MS therapies differently: They are more similar than different
Robert J. Fox and Douglas L. Arnold
Neurology 2009; 72: 1972-1973. [Full text] [PDF]  

ARTICLES
Efficacy of treatment of MS with IFNβ-1b or glatiramer acetate by monthly brain MRI in the BECOME study
D. Cadavid, L. J. Wolansky, J. Skurnick, J. Lincoln, J. Cheriyan, K. Szczepanowski, S. S. Kamin, A. R. Pachner, J. Halper, and S. D. Cook
Neurology 2009; 72: 1976-1983. [Abstract] [Full text] [PDF]  

ARTICLES
Memantine induces reversible neurologic impairment in patients with MS
P. Villoslada, G. Arrondo, J. Sepulcre, M. Alegre, and J. Artieda
Neurology 2009; 72: 1630-1633. [Abstract] [Full text] [PDF]  

EDITORIALS
Cracking the therapeutic nut in mild cognitive impairment: Better nuts and better nutcrackers
David S. Knopman
Neurology 2009; 72: 1542-1543. [Full text] [PDF]  

ARTICLES
Donepezil treatment of patients with MCI: A 48-week randomized, placebo-controlled trial
R. S. Doody, S. H. Ferris, S. Salloway, Y. Sun, R. Goldman, W. E. Watkins, Y. Xu, and A. K. Murthy
Neurology 2009; 72: 1555-1561. [Abstract] [Full text] [PDF]  

[Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

* Collected Resources Home

* Related collections:
 Clinical Trials
 All Clinical trials
 Clinical trials Randomized controlled (CONSORT agreement)
 Clinical trials Methodology/study design
 Clinical trials Systematic review/meta analysis
 Clinical trials Observational study (Cohort, Case control)
 Clinical trials Quorum


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
Copyright © 2009 by AAN Enterprises, Inc.
Advertisement